92518 CPT® code: payer coverage and prior authorization92518 appears in 8 coverage policies from Aetna, Anthem, Blue Cross & Blue Shield of Rhode Island, Blue Cross Blue Shield of Massachusetts, Regence.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Aetna | Chronic Vertigo (0238) | covered if criteria are met | Apr 23, 2026 | payer document |
| Aetna | Cochlear Implants and Auditory Brainstem Implants (0013) | covered if criteria are met | Aug 18, 2026 | payer document |
| Aetna | Endolymphatic Hydrops (Meniere's Disease) Tests (0571) | not covered | Sep 1, 2026 | payer document |
| Aetna | Evoked Potential Studies (0181) | not covered | Apr 21, 2026 | payer document |
| Anthem | Vestibular Function Testing (CG-MED-94) | covered if criteria are met | Feb 19, 2026 | payer document |
| Blue Cross & Blue Shield of Rhode Island | Vestibular Function Tests | not covered | Mar 4, 2026 | payer document |
| Blue Cross Blue Shield of Massachusetts | Vestibular Function Testing (024) | listed, no stance | payer document | |
| Regence | Vestibular Evoked Myogenic Potential Testing (Medicine 169) | listed, no stance | Jan 1, 2026 | payer document |
Prior authorization required or conditional in IN.
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.